Dr. Daniel Gyasi Spearman, MD

Dr. Spearman practices at Good Samaritan Hospital in Vincennes, Indiana, part of State of Indiana.

Dr. Spearman's NPI, 1497275887, was assigned on June 26, 2017. Dr. Spearman graduated from University Of Florida College Of Medicine in 2017. Dr. Spearman's Indiana license number on file is 01083706A.

Dr. Spearman's primary practice is Good Samaritan Hospital, at 520 S 7th St, Vincennes, IN 47591 in Knox County. The practice phone is (812) 882-5220.

Dr. Spearman's primary practice is Good Samaritan Hospital in Vincennes, Indiana, part of State of Indiana. Dr. Spearman is also affiliated with Union Hospital. The medical group on file is Midwest Emergency Medicine. Dmand AI also links Dr. Spearman to 1 more hospital, 2 medical groups and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Spearman practices, 4 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Spearman's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Spearman is board certified in emergency medicine by the American Board of Emergency Medicine. Dmand AI has Dr. Spearman's licenses on file in 2 states: Indiana and Illinois.

CMS data shows 210 Medicare services from Dr. Spearman across 3 procedure codes in 2024, for 200 Medicare patients. Medicare paid $22,913 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 200 Medicare patients who saw Dr. Spearman in 2024. The largest group is 65 to 74, with 61 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 1.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Spearman's median patient age at 49, with 56% women.

In 2024, Dr. Spearman wrote 191 Medicare Part D claims for 123 patients. 93% of them were for generic drugs. CMS names the drug for 72 of them, across 4 drugs with 11 or more claims each, at $377 in total drug cost. In 2023, CMS named 89 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Spearman for performance year 2024, reported as part of a group. Dr. Spearman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Spearman in 2014.

CMS Open Payments shows 1 general payment to Dr. Spearman from 1 drug or device company in 2024. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $19.

Dr. Spearman graduated from University Of Florida College Of Medicine in 2017.

Dr. Spearman is in network with 2 carriers, including CMS Medicare and DE State Medicaid. Medicaid plans come from the most carriers, 1. Check the plan with the practice before a visit.